Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

Clinical trial NCT01252732 · COMPLETED

Trial details

NCT number: NCT01252732
Sponsor: Melinta Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Wound Infection Abscess Systemic Inflammation Cellulitis

Start date: 2010-12-01
Primary completion: 2013-06-01
Enrollment: 1019

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.